![Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes | Nature Reviews Immunology Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes | Nature Reviews Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnri2705/MediaObjects/41577_2010_Article_BFnri2705_Fig1_HTML.jpg)
Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes | Nature Reviews Immunology
![Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes](https://pub.mdpi-res.com/diabetology/diabetology-03-00007/article_deploy/html/images/diabetology-03-00007-g003.png?1644221977)
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
![A century later, still fighting back: antigen‐specific immunotherapies for type 1 diabetes - Rodriguez‐Fernandez - 2021 - Immunology & Cell Biology - Wiley Online Library A century later, still fighting back: antigen‐specific immunotherapies for type 1 diabetes - Rodriguez‐Fernandez - 2021 - Immunology & Cell Biology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9ca8e88d-c2f8-404b-982b-600240d15855/imcb12439-fig-0002-m.jpg)
A century later, still fighting back: antigen‐specific immunotherapies for type 1 diabetes - Rodriguez‐Fernandez - 2021 - Immunology & Cell Biology - Wiley Online Library
![Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?) | Nature Reviews Endocrinology Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?) | Nature Reviews Endocrinology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41574-020-00443-4/MediaObjects/41574_2020_443_Fig1_HTML.png)